:KL1333线1a/1b

Chiara Pizzamiglio1,2, Renae J Stefanetti3,4,5, Robert McFarland3,4,5

  • 1Department of Neuromuscular Diseases, University College London Queen Square Institute of Neurology, London WC1N 3BG, UK.

PubMed
概括

这项研究发现,新型分子KL1333在健康的志愿者和患有初级线粒体疾病的患者中是安全和耐受的,有望改善疲劳和功能.